Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Stock Rated “Moderate Buy” by Sell-Side Analysts

Shares of Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) have been given an average recommendation of “Moderate Buy” by the six research firms that are currently covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and four have given a buy recommendation to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $17.20.

Several equities research analysts have recently weighed in on SENS shares. Mizuho decreased their target price on Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an “outperform” rating for the company in a research report on Wednesday, July 15th. Weiss Ratings raised Senseonics Holdings, Inc. Common Stock from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, September 17th. Finally, Wall Street Zen upgraded Senseonics Holdings, Inc. Common Stock from a “strong sell” rating to a “sell” rating in a report on Saturday, August 8th.

Senseonics Holdings, Inc. Common Stock Stock Performance

NASDAQ:SENS opened at $10.31 on Thursday. The company has a current ratio of 6.74, a quick ratio of 6.40 and a debt-to-equity ratio of 0.62. The firm has a market capitalization of $430.96 million, a price-to-earnings ratio of -4.62 and a beta of 1.02. The firm’s fifty day simple moving average is $8.55 and its 200 day simple moving average is $7.03. Senseonics Holdings, Inc. Common Stock has a twelve month low of $4.79 and a twelve month high of $11.58.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) last announced its quarterly earnings results on Thursday, August 6th. The company reported ($0.63) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.55) by ($0.08). Senseonics Holdings, Inc. Common Stock had a negative net margin of 225.09% and a negative return on equity of 165.80%. The company had revenue of $14.48 million during the quarter. As a group, equities research analysts expect that Senseonics Holdings, Inc. Common Stock will post -2.31 earnings per share for the current fiscal year.

Insider Activity at Senseonics Holdings, Inc. Common Stock

In other news, Director Douglas Roeder bought 13,953 shares of the firm’s stock in a transaction dated Wednesday, August 19th. The stock was acquired at an average cost of $8.98 per share, for a total transaction of $125,297.94. Following the completion of the purchase, the director owned 171,191 shares of the company’s stock, valued at $1,537,295.18. This trade represents a 8.87% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 4.70% of the company’s stock.

Institutional Investors Weigh In On Senseonics Holdings, Inc. Common Stock

A number of large investors have recently added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in Senseonics Holdings, Inc. Common Stock in the second quarter valued at about $15,867,000. Bank of America Corp DE bought a new position in Senseonics Holdings, Inc. Common Stock during the 2nd quarter worth approximately $2,241,000. Masters Capital Management LLC lifted its holdings in Senseonics Holdings, Inc. Common Stock by 100.0% during the 1st quarter. Masters Capital Management LLC now owns 500,000 shares of the company’s stock worth $3,330,000 after buying an additional 250,002 shares during the last quarter. Readystate Asset Management LP acquired a new position in shares of Senseonics Holdings, Inc. Common Stock in the 2nd quarter worth approximately $574,000. Finally, Penn Capital Management Company LLC acquired a new position in shares of Senseonics Holdings, Inc. Common Stock in the 2nd quarter worth approximately $535,000. 12.36% of the stock is owned by institutional investors and hedge funds.

About Senseonics Holdings, Inc. Common Stock

Senseonics Holdings, Inc is a medical technology company focused on developing and commercializing continuous glucose monitoring (CGM) systems for people with diabetes. Its products are designed to measure glucose levels continuously and provide data through a wearable transmitter and mobile application, supporting diabetes management and treatment decisions.

The company’s primary product is the Eversense CGM system, which uses a small sensor implanted under the skin and a removable, rechargeable transmitter worn over the sensor.